Lupin

Lupin

LUPIN

 ₹ 2,092.78
- ₹ 18.26
0.86%
Healthcare
 ₹ 0.00
(%)1D
Updated: 22 Oct 2024, 03:32:06 pm IST
Stock Score
Open Price
 ₹ 2,136.11
Prev. Close
 ₹ 2,111.04
 ₹ 2,083.52
Day Low
 ₹ 2,145.77
Day High

 ₹ 1,153.88
52 Week Low
 ₹ 2,286.57
52 Week High

Quick Bite

Price To Earnings Ratio

49.82

Sector PE

59.59

PB Ratio

6.73

Sector PB

8.75

EPS

42.01

Dividend Yield

0.49

Today's Volume

649.167 K

5 Day Avg. Volume

752.520 K

PEG Ratio

0.14

Market Cap.

₹ 99,430.00 Cr.

Sector
Sector
Market Cap
Market Cap

Returns Comparison

TimeLUPINVSIndustry
1 Day-0.86%-3.22%
1 Week-5.61%-5.8%
1 Month-1.63%-4.68%
6 Months16.76%16.04%
1 Year67.61%50.81%

StockGro Trade Views 👍

StockGro Trade Views 👍
Login to view TradeViews

Technical Trend

Bearish
academy home
Bearish
Neutral
Bullish

Pivot Levels

R3 ₹ 2,193.44
R2 ₹ 2,169.61
R1 ₹ 2,131.19
RESISTANCE
 ₹ 2,107.36
SUPPORT
S1 ₹ 2,068.94
S2 ₹ 2,045.11
S3 ₹ 2,006.69

Updated: 22 Jul 2024,09:18:33 am IST

Moving Averages

Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
4
Buy
2
Period (Days)SMAIndication
102161.11Bearish
202165.92Bearish
302172.4Bearish
502156.52Bearish
1002032.1Bullish
2001891.83Bullish

Updated: 22 Oct 2024, 03:15:00 pm IST

News & Events

Lupin launches first generic version of Pred Forte in United States

Ace News |  
15th Oct 2024

USFDA completes pre-approval inspection at Lupin’s Biotech facility in Pune

Ace News |  
7th Oct 2024

Lupin inks distribution pact with Scope Ophthalmics

Ace News |  
1st Oct 2024

USFDA inspects Lupins manufacturing facility at Pithampur Unit-1

Ace News |  
28th Sep 2024

Forecasts 🧭

Forecasts 🧭
Login to view Forecasts

Analyst Rankings 👍

Analyst Rankings 👍
Login to view Analyst Ranking

Shareholding Updates

PromotersDIIFIIPublicOthers
46.96%
Promoters
Sep 2024
Promoters  46.96%
FII  21.5%
DII  25.1%
Public  6.44%
Others  0%

Mutual Fund Ownership 👍

Mutual Fund Ownership 👍
Login to view Mutual Fund Ownership

Stock Score 🌟

Stock Score 🌟
Login to view Stock Score

Cash Flow

AnnualFY 2024FY 2023FY 2022
Operating Activities3648.361897.24367.31
Investing Activities-1712.20-1286.771292.23
Financing Activities-2184.21-337.25-1572.32
Net Cash Flow-248.05273.2287.22

All Figures in ₹ Cr., unless mentioned otherwise

Ratios

Return on Equity (%)

Income Statement

All Figures in ₹ Cr., unless mentioned otherwise

Balance Sheet

All Figures in ₹ Cr., unless mentioned otherwise

Peer Comparison

Name1D (%)1W (%)1M (%)6M (%)1Y (%)
Lupin-0.86-5.61-1.6316.7667.61
Alembic-3.07-13.09-16.04-10-10
Aurobindo Pharma-0.97-2.16-2.8424.0954.91
Fortis Healthcare-2.55-5.38-3.0123.6274.56
Ajanta Pharmaceuticals-6.64-11.6-5.5530.6561.04
Returns as on 22 Oct, 2024

About Lupin

Lupin Limited is a global pharmaceutical company, with products distributed in over 100 markets. The Company specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients (API). It operates predominantly in India and the United States across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health. The Company has a presence in the cardiovascular, diabetology, asthama, pediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments and also operates in the anti-TB and cephalosporins segments. Its generic formulations include Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its diabetes brands include ONDERO and ONDERO MET. Its other brands include AntaGolin, RyChol, and NeuroVance, among others.

Lupin Share Price

Lupin Limited is an Indian pharmaceutical company. The company manufactures, develops and markets a variety of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) worldwide. The company operates in the Cardiovascular, Diabetes, Asthma, Pediatric, CNS, Gastrointestinal, Anti-Infective and Non-Steroidal Anti-Inflammatory drug therapeutic segments and operates in the Anti-Tuberculosis and Cephalosporin segments. The company and its subsidiaries have manufacturing facilities in India, the United States, Mexico and Brazil, and trading and other ancillary and related activities also extend to global markets. Its complex generic portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its biosimilars include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim), and Etanercept.

Lupin FAQs

How to Buy Lupin Share?

up
To purchase Lupin shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lupin (ticker symbol: LUPIN) on the trading platform provided by your broker and purchase the shares.

What's Lupin share price today?

up
The stock price of Lupin as of 22 Oct 2024 is ₹2,092.78

What is the Market Cap of Lupin?

up
Market capitalisation represents the total market value of a company's outstanding shares. As of 22 Oct 2024, Lupin (ticker symbol: LUPIN) has a market capitalisation of approximately ₹9,94,30,00,00,000.00

What is the PE and PB ratio of Lupin?

up
Lupin Ltd's price-to-book ratio as of 22 Oct 2024 is 6.73, reflecting the market's valuation compared to its asset value. As of 22 Oct 2024, the trailing twelve months P/E (price-to-earnings) ratio is 49.82, indicating the market values the company at around ₹49.82 for every ₹1 of earnings

What is the 52 Week High and Low of Lupin Share?

up
Lupin Ltd (LUPIN) hit its 52-week high at ₹2,286.57, and its 52-week low at ₹1,153.88.
Want to learn and earn in Stocks?
Login/Register
View All Global Indices
View More
Start Learning